Share this article on:

Editorial introductions

Current Opinion in Cardiology: July 2005 - Volume 20 - Issue 4 - p
Editorial introductions

Current Opinion in Cardiology was launched in 1985. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce two of the Journal's Section Editors for this issue.

Back to Top | Article Outline

Section Editors

Edward D. Frohlich, MD

Dr Frohlich is the Alton Ochsner Distinguished Scientist at the Ochsner Clinic Foundation and staff member of the Ochsner Clinic in New Orleans. Internationally recognized for his investigative work in clinical and experimental hypertension, his clinical studies have included physiological and hemodynamic characterization of different clinical forms of hypertensive diseases including their cardiac and renal involvement. His clinical pharmacological studies have focused on all antihypertensive drug classes from the diuretics to the inhibitors of the renin-angiotensin-aldosterone system. His laboratory studies have been concerned with: development of techniques for hemodynamic assessment (electromagnetic flowmetry, radiomicrospheres for organ blood flows, echocardiography) of experimental hypertension in small animals; pathophysiological alterations of cardiac and renal involvement; and elucidation of early mechanisms of target organ involvement. He was a member of the early VA Cooperative Studies on Antihypertensive Agents and a major contributor to each of the seven Joint National Committee's national guidelines as well as the earlier 1970 guidelines.

Figure

Figure

He was Editor-in-Chief of Hypertension, an official American Heart Association (AHA) journal, from 1994 until January 2002 and Editor-in-Chief of the Journal of Laboratory and Clinical Medicine. He has served on the editorial boards of many peer-reviewed scientific journals including: Hypertension, Journal of Hypertension, Circulation, Journal of the American College of Cardiology, American Journal of Cardiology, Archives of Internal Medicine, and many others. He is the author of over 1000 peer-reviewed scientific papers and editor of several textbooks including ‘Pathophysiology: Altered Regulatory Mechanisms in Disease’ (3 editions), ‘Rypins’ Intensive Review Series' (currently in its 18th Edition), ‘Hypertension: Evaluation and Treatment’ (single author), ‘Preventive Cardiology,’ and ‘Take Heart,’ a book discussing cardiovascular risk factors for laymen. His elected memberships include the Association of American Physicians, American Society for Clinical Investigation, Central and Southern Societies for Clinical Investigation, American Physiological Society, American Society for Pharmacology and Experimental Therapeutics; and others. He has been Chairman of the Medical Advisory Board of the Council for High Blood Pressure Research, President of the American Society for Clinical Pharmacology and Therapeutics and the Society for Geriatric Cardiology and was the first Governor for Louisiana, Treasurer and member of the Boards of Governors and Trustees of the American College of Cardiology.

Dr Frohlich was presented with the Okamoto International Award in Tokyo for his ‘outstanding contributions on the pathogenesis, pathophysiology and treatment of hypertension.’ He was awarded the Distinguished Achievement Award of the AHA, the Lifetime Achievement Awards of the AHA's Council for High Blood Pressure Research and the Inter-American Society of Hypertension for his outstanding contributions to the field of hypertension research, patient care and education. He was also honored by the American College of Physicians with Mastership and Laureate Awards for distinguished contributions to the medical profession. He was elected to the Polish Academy of Arts and Sciences, received honorary degree from the University of Buenos Aires, and is an honorary member of the Colombian and Peruvian Cardiovascular Societies. He presently holds academic appointments as Professor of Medicine and of Physiology at Louisiana State University- New Orleans and Clinical Professor of Medicine and Adjunct Professor of Pharmacology at Tulane University, and was George Lynn Cross Research Professor of Medicine and Professor of Physiology and of Pharmacology at the University of Oklahoma Health Sciences Center.

Back to Top | Article Outline

William E. Boden, MD, FACC

Dr Boden is Director of the Division of Cardiology, The Henry Low Heart Center at Hartford Hospital, and Professor of Medicine, University of Connecticut School of Medicine. He earned his medical degree from State University of New York, Upstate Medical Center, Syracuse. He completed a residency in internal medicine at Boston University Medical Center, where he served as Chief Medical Resident during his last year of training. He completed a fellowship in cardiology at Tufts University School of Medicine in Boston, Massachusetts.

Figure

Figure

Dr Boden's principal research interests include post-MI secondary prevention, acute coronary syndromes and unstable angina, and hyperlipidemia in post-MI/coronary artery disease. He has worked extensively in the clinical trials arena of non-Q-wave MI and in assessing the role of calcium antagonists in patients with ischemic heart disease, notably in non-Q-wave MI secondary prevention. Involved in clinical research investigator activities as project director, study chairman, and co-chairman for multicenter clinical trials, he has served as a principal investigator, consultant, and steering committee member for numerous clinical research grant activities. He was the study chairman for the internationally acclaimed VANQWISH trial and for the INTERCEPT trial. He is also chairman for the North American COURAGE trial, the largest revascularization trial ever conducted comparing angioplasty versus medical therapy. A member of several professional organizations (notably the American Heart Association and the American College of Cardiology) and editorial boards of leading cardiology journals including American Journal of Cardiology and Journal of the American College of Cardiology, Dr Boden is also an editorial reviewer for journals such as New England Journal of Medicine, Circulation, and Journal of the American Medical Association. He has lectured widely and has an extensive bibliography, with many peer-reviewed publications, original articles, books, chapters, and abstracts to his credits.

© 2005 Lippincott Williams & Wilkins, Inc.